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Abstract
Association between Community 
Water Fluoridation Implementation 
and Bone Health: 
A Natural Experiment in Cheongju
Naae Lee
Department of Public Health
Major in Spatiotemporal Epidemiology
Graduate School of Public Health
Seoul National University
Objectives: The community water fluoridation (referred to as “CWF”) was 
conducted in Cheongju City in South Korea from 1982 to 2004. The purpose of this 
study was to evaluate epidemiologically the risk of CWF for adverse health effect, 
specifically bone related diseases (hip fracture, osteoporosis, and bone cancer).
Design: This study was an ecological study based on natural experiment design.
Methods: Study participants were residents in Cheongju from 2004 to 2013 and 
data were collected by National Health Insurance Service database. Hip fracture, 
osteoporosis, and bone cancer among adverse health diseases were selected. We 
ensured the trend of medical use trend after CWF ceased in Cheongju and analyzed 
the prevalence of selected disease to evaluate the risk of CWF. The Hierarchical 
ii
Bayesian spatio-temporal Poisson regression model which consider spatial and 
temporal correlation was performed to analyze the association between 
implementation of CWF and the prevalence of selected diseases of residents in 
Cheongju. Conditional autocorrelation (CAR) which is frequently used to control 
spatial correlation was applied in this analysis. The calculation method for Bayesian 
estimation was based on the R-INLA. 
Results: After CWF ceased in Cheongju, we observed increasing trend in hip 
fracture, osteoporosis and bone cancer in both areas (fluoridated and non-
fluoridated areas). However, there was no statically significant difference in the 
prevalence of selected bone diseases in CWF area (RR = 0.95, 95% CrI: 0.87-1.05; 
RR = 0.94, 95% CrI: 0.87-1.02; RR = 1.20 95% CrI: 0.89-1.61, respectively).
Conclusions: We used a spatiotemporal method to analyze the medical use of 
selected bone diseases from 2004 to 2013 in Cheongju with small area unit by using 
National Health Insurance Service data. Our study verified that there was no 
statistically different in prevalence of selected bone disease between CWF and non-
CWF areas after CWF was ceased. With this results, we confirmed that fluoridation 
has no negative impacts on adverse health effects. There was no clear evidence that 
exposure of CWF increased the risk on health effects. Our study provided one of the 
scientific evidence and it is necessary to research and develop as a public health 
prevention program continuously. 
………………………………………………………………………………
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Definition of community water fluoridation and history
Community water fluoridation (refer as “CWF”) is public health prevention 
program that prevents dental caries by adjusting the amount of fluoride level in 
community water system that is not harmful to human (CDC, 2016). In January of 
1945, CWF was implemented first in the world in Grand Rapids, Michigan and 
Newburgh, New York in the United States with concentration of 1ppm (1.0 parts of 
per million) as part of case study (Crawford, 1995). In the same year in May, it 
began in Brantford, Ontario in Canada (Rabb-Waytowich, 2015). After the results 
of the effects of these programs were published between 1950s to 1960s, many 
countries such as Australia, Brazil, Ireland, New Zealand, the United Kingdom, and 
elsewhere has been implemented CWF program (Hutton et al., 1951; Ludwig, 1965; 
Jones et al., 2005). With seventy-years history of CWF, fluoridation of drinking 
water has been declared the ten greatest public health achievements of the 20th
century by the Centers for Disease Control (CDC). CWF considered as the safest 
and highest cost-effectiveness methods of preventing tooth decay regardless of 
socioeconomic status and it actively conducted by many developed countries, as it 
is recommended by the World Health Organization (WHO) (Klein et al., 1985).
２
Debate continues over community water fluoridation
The positive effects of CWF program already has been confirmed in published in
many scientific literatures in various of countries. With health and economic 
benefits, fluoridation is the most effective way of preventing and controlling dental 
caries and many countries has already been proved effectiveness of water 
fluoridation (Kanduti et al., 2016). Considering the effect of prevention of dental 
caries and efficiency, it is the minimum national prevention program for oral health 
and can ease the financial burden of the state (Moore et al., 2017). The fact that 
CWF has been proven safe as a public health prevention program was revealed in 
the global implementation status. For the meantime, a systematic review of CWF 
and health impacts through 25 databases conducted and it concluded that there was 
no evidence of potential adverse effects, although decrease in dental caries ought to 
be considered with increase of dental fluorosis at the same time (McDonagh et al, 
2000). Despite numerous studies and countless tests were performed over the 
seventy-years records, opponents claimed for cessation with growing on the premise 
of negative outcomes or adverse health effects through accumulation of fluoride in 
bone (Whitford, 1989; Levy et al., 2014) 
History and current status of community water fluoridation in Korea
The Ministry of Health and Welfare of the Republic of Korea enacted the provisions
of fluoridation in community water sources in 1980. Since then, in April 1981,
３
CWF has implemented in Jinhae City in Gyeonsangnam-do Province, and Cheongju 
City in Chungcheongbuk-do Province in February 1982 as case studies (Kim et al., 
1996). As the effectiveness and safety of CWF known to the public, it has expanded 
in earnest. Later, the government expanded to 37 water treatment plants (include 32 
local governments) and covered 4.43 million populations in 2002 (roughly 9.4% of 
the Korean population) in 2002 (Kim et al., 2019).
Previous studies on the prevention effect of dental caries due to 
fluoridation have been widely published in Korea. A survey on children (6 to 11 
years old) who have lived in Cheongju (CWF area) or Seongnam (non-CWF area), 
showed that the rate of permanent dental caries prevention was 35.4% (Kim et al., 
1997). Another study reported that children’s dental caries reduced in Ansan (CWF
area) compared to Geoje (non-CWF area) (Han et al., 2011). As such, there were 
many studies that have shown the effect of preventing dental caries by comparing 
children in CWF and non-CWF areas. In addition, many epidemiological studies 
have been conducted on human health effects and number of studies have been 
reported on bone density and fractures. Many previous studies confirmed that there 
was no significant risk of safety and adverse health effects such as bone related 
disease (fractures, bone mineral density, osteosarcoma studies). Even so, anti-
fluoridation activities have intervened, and they argued for cessation of CWF in 
Korea with following reasons: 1) Fluoride classified as a neurotoxin, 2) CWF can 
cause dental fluorosis, 3) Safety issues regard with adverse health effects has not 
been properly evaluated, 4) It violates individual’s option by putting fluoride in 
４
public water system. 
The pros and cons of CWF are still debating and open discussion are 
performing. Many local governments had ceased CWF by anti-fluoridation 
activities and considered the claims of local residents. This situation considered as 
“opportunist epidemiology” which result an unplanned break cause of opponents 
(Burt et al., 2000). In [Figure 1], it displays the number of operating water treatment 
plants and local governments in Korea. Based on the information, only 8 local 
governments out of 226 (3.5% of local governments, include 12 water treatments 
plants) are operating CWF program in Korea (Ministry of Health and Welfare, 
2018). 
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Source: Ministry of Health and Welfare, 2018
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1.2 Literature review
A systematic review was conducted to identify the association between CWF and 
bone diseases. Also, we conducted a literature review about ecological studies, 
especially, focusing on natural experiment design to review previous studies. All the 
processes of literature search were based on the PRISMA, a systematic review and 
meta-analysis research report format. We searched PubMed and Embase as 
international databases (search date: 2019.5.1. ~2019.5.5.), and Korean Medical 
database (KM base), National Digital Science Library (NDSL), and Research 
Information Sharing Service (RISS) were used as national databases (search date: 
2019.5.6. ~2019.5.7.). 
Association between bone diseases and community water fluoridation
In international and national databases, detailed searches (advanced) were used to 
search for key terms related to “water fluoridation” in “all fields” tap and “bone”
such as “fracture” or “osteoporosis” or “bone mineral density” in this study [Table 
1]. Through screening 1, we excluded not relevant topics, non-article formats such 
as abstract, letters, review, supplementary, commentary. In screening 2, we 
excluded ineligible outcomes and animal studies. With this process, 40 studies were 
relevant to our study [Figure 2]. 
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We summarized each previous studies relate with water fluoridation and 
bone diseases [Appendix. A]. We arranged the studies in yearly order, defined study
country, study design, population by number of participants, disease outcome, 
outcome measurements, and presence of risk (if the study reported the risk than 
marked as yes (Y), otherwise no (N)). The study designs used included 11 case-
control (include matched case-control) studies, 6 cohorts (prospective or
retrospective or multicenter prospective) studies, 8 cross-sectional studies, 13
ecological studies and 2 hybrids (ecological cohort and ecological prospective)
studies. In 40 studies, the outcome of 9 studies were osteosarcoma (most common
form of bone cancer), rest of 31 studies were observed fractures include hip, wrist,
ankle with measurement of bone mineral density. Most of studies were compared
the residents’ health outcome between fluoridated and non-fluoridated areas or
patients who have lived in a community with low concentration rate of fluoride.
Throughout the systematic review, most studies have found that there was 
no significant association between CWF and bone diseases. Many studies have been 
linked to fractures with bone mineral density. In our study, we will specifically 
focus on the risk of hip fracture, osteoporosis and bone cancer in fluoridated 
drinking water. 
8




(“Fluoridation”[MeSH] OR “CWF” OR “water fluoridation” OR “Fluoride”[MeSH]) 
AND (“Hip fracture”[MeSH] OR “Fracture” OR “Bone cancer” OR 
“Osteosarcoma”[MeSH] OR “Osteoporosis”[MeSH] OR “Bone Density”[MeSH] OR 
“Bone strength” OR “Bone fragility”) AND (“Public health” [MeSH] OR 
“Epidemiology” [MeSH] OR “Health” [MeSH] OR “Disease”[MeSH])
Embase
#1
(‘Fluoridation’ OR ‘water fluoridation’ OR ‘CWF’) AND (‘Hip fracture’ OR ‘Fractures’ 
OR ‘Bone cancer’ OR ‘Osteosarcoma’ OR ‘Osteoporosis’ OR ‘Bone Density’ OR ‘Bone 
strength’ OR ‘Bone fragility’) AND ('Public health'/exp OR ‘public health’ OR 




KM base “Fluoridation” AND “Bone”
NDSL
(‘Water fluoridation’|‘Fluoridation’|‘Community water fluoridation’) <AND> 
(‘Fracture’|‘Bone density’|‘Osteoporosis’|‘Osteosarcoma’|‘Bone’)
RISS
(‘Water fluoridation’|‘Fluoridation’|‘Community water fluoridation’) <AND> 
(‘Fracture’|‘Bone density’|‘Osteoporosis’ |‘Osteosarcoma’|‘Bone’)
Note.
∙ Abbreviations: MeSH, Medical Subject Headings
9
Figure 2. Flow diagram of literature and selection criteria about bone diseases.
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Community water fluoridation with natural experiment
In international and national databases, detailed searches (advanced) were used to 
search for terms related to “water fluoridation” in “all fields” tap and “natural 
experiment” [Table 3]. 
We found 13 studies in the databases but since natural experiment related 
to CWF considered as rare case, we only had 4 studies after removed duplicate 
articles. Thus, we conducted one time of screening in this review. Then, we
excluded studies that were not relevant to topic, and with this process, we have 
found that 2 studies were relevant to our study [Figure 3]. 
In [Table 3], we summarized the previous studies that were relevant to 
water fluoridation with natural experiment design. We arranged the studies in yearly
order, defined study country, study design, population by number of participants, 
outcome, measurements and association of risk. Reviewed studies were compared
the health outcome, focused on dental caries by compare fluoridated and non-
fluoridated areas. In Brazil study, they investigated dental outcomes with a 
population-based cohort study names EpiFloripa and matched with participant’s 
residency to tract the exposure of fluoridated water. The study reported that adults 
with lower the lifetime access to fluoridated water had the higher rate of decayed, 
missing, and filled teeth (DMFT): lifetime access to fluoridated water for less than 
50% (RR: 2.70, 95% CI: 2.01-3.63) was higher than 50% to 70% (RR: 1.93, 95% 
CI: 1.39-2.68) on DMFT rate ratio (Peres et al., 2016). The study result was 
consistent with a recent Cochrane DB of systematic review on the effectiveness of 
11
water fluoridation on adult dental caries (Iheozor Ejiofor‐ et al., 2015). In Canada 
study, they examined dental caries incidences among children with a pre-post cross-
sectional design with comparison CWF cessation area and continued area. They 
have found an increase in primary teeth mean deft as 37% (RR: 1.37, 95% CI: 1.25-
1.51) in cessation area (McLaren et al., 2017).
With the systematic review of studies, we have found that selected studies 
were related to fluoridation with natural experiment design have been limited to 
dental caries only and reported that there was no statistically significant risk in
drinking fluoridated water. To be differentiate, our study, we will investigate the 
association of bone health with natural experiment design.  
12




(“Fluoridation”[Mesh] OR “Community water fluoridation” OR “CWF” OR “water 
fluoridation” OR “Fluoride”[Mesh]) AND (“Natural experiment”)
Embase
(‘Fluoridation’ OR ‘Community water fluoridation’ OR ‘CWF’ OR ‘water fluoridation’) 
AND (‘Natural experiment’)
National
KM base “Natural experiment”
NDSL
(‘Water fluoridation’|‘Fluoridation’|‘Community water fluoridation’) <AND> (‘Natural 
experiment’)
RISS
(‘Water fluoridation’|‘Fluoridation’|‘Community water fluoridation’) <AND> (‘Natural 
experiment’)
Note.
∙ Abbreviations: MeSH, Medical Subject Headings
13
Figure 3. Flow diagram of literature and selection criteria about natural experiment.
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There are limited current epidemiological studies that have assessed the adverse
health effects of water fluoridation. The purpose of this study is to analyze the 
adverse health effects of CWF based on the prevalence of bone diseases (hip 
fracture, osteoporosis, bone cancer). 
The study is conducted in three successive objectives, each building on the 
previous ones.
Objective 1: Identify the current status and adverse health outcome of water 
fluoridation in Korea through recent literature reviews.
Objective 2: To compare the prevalence of selected bone diseases (hip fracture, 
osteoporosis, and bone cancer) among the residents in Cheongju.
Objective 3: Epidemiologically, investigated the risk of health outcome through 
fluoridation with spatio-temporal method.
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CHPATER 2. METHODS
2.1 Study design, and setting 
This is an ecological study in the form of natural experiment design. We chose 
Cheongju as study area because naturally experimental situations occurred without 
researcher’s intervention or control of the area. Cheongju was the second area
where CWF program was conducted on a trial case in Korea, and implemented for 
about 22 years from 1982 to 2004. Cheongju consists of 23 towns and residents has 
been supplied community water source from two local water treatment plants: 
Yeong-un and Ji-buk. In two water treatment plants, 14 towns were supplied with 
fluoridated water and 9 towns were supplied with non-fluoridated water. We 
mapped the status of CWF in Cheongju [Figure 4]. In [Figure 4 (A)], it indicates the 
province of Cheongju (Chungcheongbuk-do) in Korea and in [Figure 4(B)], it
indicates Cheongju in the province. In [Figure 4 (C)], it showed the status of CWF 
in Cheongju. Light pink areas represented that CWF implemented for 22 years from 
1982 to 2004, and the dark red areas implemented CWF for 7 years from 1997 to 
2004. Rest of regions colored in white represented the area where CWF never 
conducted.
In order to investigate the risk of CWF, a control group was needed who 
have similar population characteristics as case group but never exposed to 
fluoridated water to compare adverse health effects. Cheongju was divided into two 
regions where fluoridation and non-fluoridation area within the same area, unlikely
17
other areas where conduct CWF program in whole region. Consequently, Cheongju 
considered as the most suitable area for present study and perfect condition of 




Figure 4. Status of Community water fluoridation implementation in Cheongju 





2.2 Data descriptions and study subjects
In our study, we examined the adverse health effects of residents in Cheongju. We 
extracted data from 2004 to 2013 from the National Health Insurance Service
(NHIS) database. The NHIS is Korean healthcare insurance of governmental 
organization under the Ministry of Health and Welfare (Chung et al., 2018). We 
requested the customized database for academic research purpose and it included
information regarding medical utilization information in smallest administrative 
unit, town (i.e., Eup/Myeon/Dong in Korea). This claims data represents the whole 
population in Korea since 98% of the population is covered by the national health 
insurance (Lee et al., 2018). Since we have requested customized data from NHIS, 
there were no missing information and obtained each of the selected diseases in the 
form of frequency by gender, year, age, and address in town.
The study population were all residence in Cheongju, obtained medical 
utilization information of patients were obtained from NHIS. Among them, we have 
used residents who were diagnosed with hip fracture or osteoporosis or bone cancer.
Medical utilization information of selected disease was collected in the form of 
frequency by age and gender group and, twenty-year intervals were used for age 
categorization in the analysis.
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2.3 Variables 
We have chosen bone disease as outcome variables. The most common findings of 
the results of adverse health effects related to CWF were bone diseases. Most 
studies have been published that there was no association or risk between CWF and 
bone diseases (fracture, bone density, osteoporosis, osteosarcoma, and others) 
through systematic reviews but since there were lack of epidemiological studies 
with natural experiments design, we have targeted bone diseases that are most likely 
to be associated with fluoride and adverse health effects. Among the diseases 
classified by the KCD-7 based on the International Classification of Diseases 
(ICD)-10, three types of bone diseases that were known to be relevant to CWF were 
selected: hip fracture (S72), osteoporosis (M80-82), and bone cancer (C40-41)
(WHO, 1992) [Table 4]. For three selected diseases, age-sex standardized rates per 
10,000 person-years were calculated with the corresponding population in 
fluoridated and non-fluoridated areas and we applied 2010 Census in Korea as 
standard population. 
For the independent variables, we set the time variable from 2004 to 2013 
and spatial variable which was designated based on CWF implementation status. In 
addition, general variables such as gender, age, population density, and number of 
towns were used to compare the characteristics between CWF and non-CWF areas.
Also, we used the variables related to the exposure of fluoridation such as period of 
residence, source of water, and types of drinking water. We obtained theses
customized data from Korean Microdata Integrated Service (MIDS) of statistics 
21
Korea (MicroData, 2018). Microdata represents the data that is modified the errors 
and basis of data processing such as statistical tables. Among these, we extracted 
questionnaire that is related with exposure of fluoride of household information in 
the 2010 Census data.
22
Table 4. Classification of disease that were used as outcome variables 
Classification KCD-7* Disease codes
Hip fracture S72 Fracture of femur
Osteoporosis
M80 Osteoporosis with pathological fracture
M81 Osteoporosis without pathological fracture
M82 Osteoporosis in diseases classified elsewhere
Bone cancer
C40
Malignant neoplasm of bone and articular 
cartilage of limbs
C41
Malignant neoplasm of bone and articular 
cartilage of other and unspecified sites




In order to check the space and time correlation in prevalence of three bone diseases, 
we measured the disease risk by calculating standardized incidence ratios (SIRs)
which consider as the one of simple measure of disease risk in areas (Moraga, 2018).
An observed count in each areal unit i expressed as Y = (  , … ,   ) and a set of 
expected disease counts in area i is given by E = (  ,… ,    ). These expected 
counts calculated based on the age and sex demographics of population within each 





A value of SIR higher than 1 represents that an area has a higher disease 
risk than expected, while a value of SIRs under 1 suggests a lower risk compare to 
expected. In some conditions, SIRs might have the disease’s spatial variability and 
extreme values with small sample sizes (Anderson et al., 2017; Gelfand et al., 2010). 
We mapped the average value of the SIRs in three different years to observe the 
space and time correlation [Figure 5]. SIR for different towns were shown to be 
different over time, and bone cancer was found to have relatively lower SIRs 
compared to the two different diseases. We plotted the temporal trends for three 
selected diseases after adjusting age and sex using 2010 Census from 2004 to 2013. 
(Figure 3). Overall, selected diseases tend to increase year to year, but the trend of 
24
hip fracture and osteoporosis were similar in CWF and non-CWF regions. For bone 
cancer, it appears to be different due to the number of patients was so small so it 
was not statistically significant. Therefore, to analyze this disease count data, a 




Figure 5. Standardized incidence ratios (  /  ) in three different years; 2004, 2009 and 2013
26
C) Bone cancer
Figure 5. Standardized incidence ratios (  /  ) in three different years; 2004, 2009 and 2013. (Continued)
27




In our study, we conducted a hierarchical Bayesian Poisson regression model that 
takes into account space and time correlations to model the relationship between 
CWF and the standardized prevalence of three selected diseases among Cheongju 
residents. Bayesian spatio-temporal models were developed from many authors, and 
we adapted the general time trend model proposed by Knorr-Held since our study 
consider temporal development of the association between three selected disease
and water fluoridation through space and time interactions (Bernardinelli et al., 
1995; Knorr-Held, 2000; Blangiardo et al., 2015). 
We used observed and expected count data in yearly of three bone diseases 
in Cheongju. The Poisson regression model, which takes into account spatial 
correlation and time trends, is used to calculate the relative risk and 95% credible 
interval. The Conditional Autoregressive (CAR) model was applied to control 
spatial correlation. In this paper, we used an integrated nested Laplace 
approximation (INLA) in R package to estimate Bayesian inference in latent 
Gaussian models (Schrödle, 2011). We also used the Deviance Information 
Criterion (DIC) to compare the quality of the model fit. Generally, DIC is a 
Bayesian analogue of the Akaike Information Criterion (AIC) and test the 
goodness-of-fit and complexity (Luan et al., 2016). The best fitting model consider 
as the one with the lowest value of the absolute scale of DIC with reasonable 
computational time (Lunn et al., 2012). The equation of DIC is shown where    is 
29
the mean deviance which favors a good fit and    is effective number of 
parameters. 
DIC =    +  
   =	   +   
(2)
To describe each type of integration, for Type 1 interaction, if two 
unstructured main effects υ	   	ϑ are expected to interact δ, then all interaction 
parameters     is a priori independent. Type 2 is to combine random walk main 
effect α with the unstructured block ϑ , then each    = (  , … ,    )
 , i = 1,… , n
follows random walk apart from other counties. In the case of type 3, the main 
effects γ and θ interact, then Type 3,    = (  , … ,    )
 , t = 1,… , T, (independently) 
follows an intrinsic autoregression. Finally, Type 4 yields two dependent main 
effects, the random walk and the intrinsic autoregression, ϑ, as the most interesting 
interaction type from a theoretical point of view. R-INLA coding for four types of 
interaction is presented in [Appendix C]. To find the best fitted model, we presented 
the value of DIC for each type of interactions in three bone diseases using R-INLA 
[Table 5]. Among the four models described above, the more suitable model 
selected Type 1 according to the principle that it has a smaller DIC value. In the 
case of osteoporosis, type 2, 3, and 4 were too large, and for bone cancer, type 3 has 
small DIC value. Overall, Type 1 interaction is most appropriate.
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With number of observed data in each Cheongju (town unit, i = 1,…,28) 
and time period in year (t = 1,…,10), we present a Poisson distribution of spatio-
temporal model based on Knorr-Held as follows:
    	~	        E      ,  ,   = 1,… ,  ,   = 1,… ,  ,
       =	 λ   =       ,
log      =	    
   +   ( ) +    +    +   
(3)
where    
   is an overall risk level,   ( ) represents the spatial level for 
the i-th area (town unit, i = 1,…,28) which consider the spatial correlation, and   
has the same meaning as   ( ), which represents the spatial level for the j-th area
(town unit, j = 1,…,28) that equivalent to unique regional variations.    represents
temporal effects from 2004 to 2013 (t=1,…,10), and     represents spaceⅹtime 
interaction.
Sensitivity analysis
Also, we used CARBayesST package in R based on Markov chain Monte 
Carlo (MCMC) simulation to compared several models which applied the spatial 
temporal interaction. Sensitivity analysis can explain similarities and differences 
between models. We have used models that take into account spatial and temporal 
correlations. CARBayesST is the first proprietary software package for spatio-
temporal unit modeling with CAR prior (Lee et al., 2018). We compared the DIC 
value in two different packages in order to ensure that the model we chose to 
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describe the best of our data. The models were compared in three key criteria: 
calculation time,    and model fit. The quality of the model fit is defined using 
DIC (Equation (2)). Model with the lowest DIC can be considered to provide the 
closest fit to the observed data (Lunn et al., 2012; Anderson et al., 2017).
Ethics Statement
This study was approved by the Institutional Review Board of the Seoul National 
University (IRB No. E1903/003-006).
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Table 5. The DIC values for type comparison with selected bone diseases
Interaction    
Parameter 
interacting
Hip fracture Osteoporosis Bone cancer
DIC
Type 1    and φ  2158.1 3241.2 1021.6
Type 2    and γ  2403.5 11441.6 2774.0
Type 3 φ  and    2398.3 11442.2 1031.6
Type 4    and γ  2404.0 11440.4 2.42 
  
Note.
∙ Bold number represents the lowest DIC value in the table.
∙ Supplementary programming code (R-INLA) is in Appendix B.
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CHAPTER 3. RESULTS
3.1 General characteristics of study population
In [Table 6], we showed the general characteristics of study population in Cheongju 
and observed the regional difference between CWF and non-CWF areas. All 
variables except population density and number of towns are expressed as 
frequency and percentage (%). Intuitively, number of population was about twice 
higher in CWF than non-CWF, but proportion of gender was about the same in both 
areas. By age group, 20-39 years old (33.4%) was highest group in CWF area and 
40-59 years old (35.8%) was highest in non-CWF area. In the case of population 
density, CWF area was about 1.5 times higher than non-CWF area, and number of 
towns in CWF area was 2.3 times higher than non-CWF area. In both regions, 
drinking tap water had the highest portion (CWF: 47.8%, non-CWF: 45.5%). This 
directly shows that both regions were exposed to fluoridated water at a similar rate. 
There was no significant regional difference in education level, source of water and 
types of drinking water.
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Table 6. The distribution of general characteristics in CWF and non-CWF areas from 2004 to 2013.
Variables
CWF non-CWF
No. of residents % No. of residents %
Total 4,406,021 2,270,959
Gender
   Male 2 200 104 49.9 1 126 495 49.6
   Female 2 205 917 50.1 1 144 464 50.4
Age (years)
   < 20 1 135 966 25.8 603 984 26.6
   20 – 39 1 473 753 33.4 650 749 28.7
   40 – 59 1 292 255 29.3 813 074 35.8
   60 – 79 445 321 10.1 177 593 7.8
   80 ≥ 58 726 1.33 25 559 1.13
Population density (people per km2) 5.1 3.4
Number of towns (N) 21 9
Education level*
   Middle school or lower 1 689 36.8 2 541 34.9
   High school 1 433 31.2 2 140 29.4
   College or higher 1 469 32.0 2 607 35.8
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Table 6. Distribution of general characteristics in CWF and non-CWF regions from 2004 to 2013. (Continued)
Variables
CWF non-CWF
No. of residents % No. of residents %
Period of residence*
   > 1 year 324 23.5 691 34.1
   1 – 5 years 493 35.8 1 002 49.4
   5 – 10 years 397 28.9 462 22.8
   10 – 25 years 362 26.3 461 22.7
   < 25 years 124 9.01 104 5.13
Source of water*
   Community water system 4 363 98.8 2 681 98.6
   Village water (temporal) 6 0.14 0 0.00
   None 49 1.11 39 1.43
Types of drinking water
   Drinking tap water 812 47.8 1 237 45.5
   Purified tap water 524 30.9 860 31.6
   Bottled water 238 14.0 427 15.7
   Others 124 691 7.30 196 7.21
Note.
* indicate that data obtain from Microdata Integrated Service of 2010 Korean Census
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3.2 Comparison of crude and age-sex standardized rates
Present study analyzed 7,751 cases of hip fracture (male: 2,830, female: 4,921), 
128,211 cases of osteoporosis (male: 11,595, female: 116,616), and 528 cases of 
bone cancer (male:312, female: 216) [Table 6]. Depending on CWF implementation 
status, we categorized into gender and age distribution (under or above 80 years old)
for each selected disease and calculated the crude rate per 10,000 person-years. In 
terms of gender, the number of observed counts was higher in female with hip 
fracture and osteoporosis regardless exposure of fluoridation, and the crude rate was 
about twice higher in female than male. In the case of bone cancer, both regions had 
higher rate in male (CWF: 1.11 in male, 0.73 in female; non-CWF: 0.59 in male, 
0.47 in female). Based on the age of 80 years old, the crude rate of over 80 years old 
was higher than patients who were under 80 years old in all diseases, which it is 
commonly known that bone strength or bone density getting weaker as they become 
older (Ringertz et al., 1997). 
To describe the data, we plotted the temporal trends for three selected 
diseases after adjust age and sex using 2010 Census as the standard population from 
2004 to 2013. The shape of age-sex adjusted standardized rates per 10,000 person-
years for all diseases tend to increase year to year [Figure 5]. For hip fracture, age-
sex standardized rates are higher in non-CWF area and for osteoporosis, it was
increasing in non-CWF as time goes. Compared to the other diseases, the trend for 
bone cancer was higher in CWF than non-CWF area. However, there was no 
statistically significant difference since number of diagnosed patients were very 
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small. In both regions, the prevalence of three selected diseases were tend to 
increase over the period of time, but this can interpret as natural phenomenon 
include many other risk factors, not typically impact of CWF.
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Table 7. Number of cases, crude rates per 10,000 person-years of three selected diseases in CWF and non-CWF areas.
Variables
CWF non-CWF
No. of patients Crude rate* No. of patients Crude rate*
Hip fracture
   Male 1,965 8.9 865 7.7
   Female 3,366 15.3 1,555 13.6
   Under 80 years old 3,746 8.62 1,715 7.64
  Above 80 years old 1,585 269.90 705 275.83
Osteoporosis
   Male 8,025 36.5 3,570 31.7
   Female 82,667 374.8 33,949 296.6
   Under 80 years old 83,111 191.18 34,306 152.78
  Above 80 years old 7,581 1290.91 3,213 1257.09
Bone cancer
   Male 245 1.11 67 0.59
   Female 162 0.73 54 0.47
   Under 80 years old 386 0.89 118 0.53
  Above 80 years old 21 3.58 3 1.17
Note. 
*: Crude rate per 10,000 person-years
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3.3 Comparison of the relative risk of selected diseases 
We used the Bayesian spatio-temporal regression using the R-INLA package to 
determine whether each bone diseases increases with fluoridation exposure period. 
From [Table 8], in the case of hip fracture, the relative risk in CWF is 0.94 (95% 
CrI: 0.86-1.04), and for osteoporosis, it was 0.94 (95% CrI: 0.87-1.02). Relative risk 
in hip fractures and osteoporosis are less than 1 indicate that the risk of CWF did 
not increased. On the other hand, the relative risk of bone cancer was 1.20 (95% CrI: 
0.89-1.61), which was relatively higher than other diseases but the result of bone 
cancer was difficult to interpret as statically significant because the number of 
patients was very small since it considers as a rare case.
We compared the relative risk by gender. The relative risk for hip fracture 
in male and female were 0.88 and 0.99, and for osteoporosis were 0.86 and 0.95, 
respectively. Particularly, hip fractures and osteoporosis were significantly higher in 
females than in males. This because hormone’s changes in men were not as large as 
in women, and women have higher bone loss due to menopause which is not 
equivalent that loss of testosterone and E-level with age in men (Khosla et al., 1998). 
Additionally, previous study reported that fluoride reduce the risk of fractures by 
increasing bone mass and it use as one of therapy of male osteoporosis (Tuck et al., 
2007). That explains why the relative risk for hip fracture and osteoporosis were 
higher in female than in male.
In addition, we calculate the relative risk by time difference [Appendix D]. 
On the contrary, the relative risk was higher in the long-term (conducted from 1982 
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to 2004) than short-term (conducted from 1997 to 2004) exposure area. This 
indicates that exposure to fluoridation for long periods of time does not increase the 
risk to human health. In the case of bone cancer, the relative risk has different 
aspects than other two diseases, but this was not statistically significant with small 
number of cases.
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Table 8. Posterior distribution of relative risks with 95% credible intervals in total, male and female.
Total Male Female
RR* (95% CrI**)
Hip Fracture 0.94 (0.86 - 1.04) 0.88 (0.75 – 1.01) 0.99 (0.89 - 1.09)
Osteoporosis 0.94 (0.87 – 1.02) 0.86 (0.76 – 0.97) 0.95 (0.87 - 1.03)
Bone Cancer 1.20 (0.89 - 1.61) 1.26 (0.84 – 1.88) 1.03 (0.87 – 1.22)
Note.
*  RR: Relative risk
** 95% CrI: 95% Credible Interval
∙ Supplementary programming code (R-INLA) is in Appendix B.
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3.4 Disease mapping of selected diseases
Three-year period (2004, 2009, and 2013) between 2004 to 2013 were used to map 
the posterior distribution of relative risk for the selected disease [Figure 6]. The 
results of disease mapping reflect time trend from 2004 to 2013 and primarily 
focused on change in prevalence of selected bone diseases over the time. The area 
marked with bold line was the region where CWF was implemented, and the other 
area was classified as non-CWF area where CWF was never conducted. On the 
right side of the map, legend of the relative risk value is displayed from 0.85 to 1.80
and the color of blue represented a relatively lower risk and the red color 
represented a higher risk. Overall, the color of the map represents the prevalence of 
selected disease increased over time, but we ensured that intuitively there was no 
significant difference between CWF and non-CWF areas which is consistent with 
previous results conducted by R-INLA [Table8]. 
In addition, we also present disease mapping that divided into three 
different regions depend of duration of the period of time of CWF [Appendix E].
One area (yellow dotted line) was the area where CWF conducted from 1982 to
2004 (consider as long-term exposure), the other area (purple bold line) was the
area where CWF conducted from 1997 to 2004 (consider as short-term exposure)
and rest of region never implemented CWF. Likewise, the prevalence of all selected
diseases tend to increase but the disease risk reveals no difference in the period of
time (short and long-term exposure).
43
A) Hip fracture 
B) Osteoporosis




∙ Bold line region: CWF was conducted and rest of region: CWF never implemented
Figure 7. Spatial distribution of posterior relative risk by town and year in 2004, 2009, and 2013. (Continued)
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3.5 Comparison of the performance of the models
We applied Model 1 to 5 to the dataset using the CARBayesST software in R and 
displayed the result of computation time, DIC value, effective number of parameters
(  ) for each of the five selected models [Table 9]. We have added a reference to 
the five models and summarized table shown in [Appendix F] (Lee et al., 2018). 
Each model was fitted to calculate DIC generated by a MCMC simulation, and in 
each case, 50,000 interactions were discarded as burn-in. In terms of   , small 
relative to the number of data points will be approximately equal to the actual 
number of parameters and it consider as spatial and temporal autocorrelation of our 
dataset (Best et al., 2005; Luan et al., 2016).
For hip fracture, the best fitting model by the DIC criterion is Model
4since it has lowest DIC value of 2007.7 with 545.3 seconds. Next, the best model
is DIC value of 2029.2 with 389.9 second in Model 5. Followed by Model 3 with 
2102.4, and lastly DIC value for Model 1 is 2118.5. For osteoporosis, Model 4 has 
lowest DIC with a value of 2001.8 with 478.9 seconds and the next best value of 
DIC is 2029.3 in Model 5. Then, Model 3 (3272.0), Model 1 (3821.7) and then 
Model 2 (6163.7). For bone cancer, Model 3 has lowest DIC value of 1011.2 with 
100.6 seconds. Followed by, Model 2 with 1026.1, and then Model 1 with 1029.3, 
and then Model 4 (2004.9), and Model 5 (2027.5), respectively.
Although Model 4 has lowest DIC value in hip fracture and osteoporosis 
but it took a longer computational time. Consequently, Model 1 appears to be best 
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choice over all in all three diseases since the DIC value is consistent with previous
R-INLA results in [Table 8] and it has reasonable computation time compare to
other models.
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Table 9. Comparison of the values of DIC between the models for selected bone diseases.
R package Model
Hip fracture Osteoporosis Bone cancer




142.9 2118.5 171.8 147.1 3821.7 353.7 162.3 1029.3 29.4
Model 2: 
CARlinear
132.2 2123.8 52.7 127.9 6163.7 65.3 141.1 1026.1 24.4
Model 3: CARar 98.5 2102.4 151.6 102.8 3272.0 323.6 100.6 1011.2 42.3
Model 4: 
CARadaptive
545.3 2007.7 74.2 478.9 2001.8 72.3 480.8 2004.9 72.0
Model 5: 
CARlocalised
389.9 2029.2 109.6 374.3 2029.3 108.8 388.2 2027.5 109.3
R-INLA Type 1 interaction 3.23 2100.1 159.7 2.76 3212.3 304.8 2.24 1021.7 21.9
Note.
*  pD : Effective number of parameters
∙ Supplementary programming code is in Appendix C.
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CHAPTER 4. DISCUSSION
4.1 Summary of results: A new finding of this study
To our knowledge, our study has attempted to investigate the association between 
exposure of fluoridation and adverse health effect, specifically bone diseases with 
natural experiment design. Ecological analysis used high-quality population based 
on NHIS data which are considered to be representative of the Korea’s population. 
As a result of spatio-temporal analysis with town unit, prevalence of all three 
selected diseases in Cheongju showed a tendency to increase from year to year, 
however it was not statistically significant difference in CWF area compared to 
non-CWF area. This study results confirmed that there was no clear evidence of 
adverse health effects associated with residence in areas with water fluoridation. 
4.2 Comparison with previous studies
A large number of results of studies on fluoride exposure and bone diseases were
mainly focused on fractures. These findings are generally consistent with previous
study results. Meta-analysis confirmed that chronic fluoride exposure from drinking 
water does not significantly increase the risk of hip fracture and in the United States,
long term exposure to fluoridated drinking water does not increase the risk of 
fracture (Yin et al., 2015; Phipps et al., 2000). In addition to Ireland study, there 
was no significant relationship between water fluoridation and bone health among 
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older adults (O’ Sullivan et al., 2015). Likewise, our study consistent with previous 
results that the risk of bone disease has not increased since the prevalence did not
increased in those residents who exposed to fluoridated water (Public Health 
England, 2014). Moreover, the benefits associated with preventing dental caries 
from conducting CWF in town were evident in previous study in Cheongju (Kim et 
al., 2014). Our study presented not only hip fracture but also prevalence of 
osteoporosis and bone cancer, and the epidemiological analysis by natural 
experimental design is a distinction from other studies.
4.3 Strengths and Limitations of this study
There are several important limitations in this study. First, on the exposed side, it 
was not clear to find out how much of residents are exposed to fluoridated water in 
CWF area. Non-differential misclassification can occur because individual exposure 
is unknown, and it may be appearing that there is no difference in prevalence 
between the two areas due to toward null. However, the ratio of drinking tap water 
in both regions was about the same (CWF: 47.8%, non-CWF: 45.5%). This means 
that small amount of fluoride in one region has also been less exposed in another 
region, so there will be no error in the interpret the consequences of bias. Second, 
exposure should be long enough depending on the dose-response relationship in 
order to develop the disease in relation to fluoridation. Though, the percentage of 
people who lived in the region for more than twenty-five years is small at 9.01% in 
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CWF and 5.13% in non-CWF, respectively, which can cause no difference in the 
prevalence. Despite the difference in the proportion of people who have lived long 
between the two regions, it would be difficult to see a difference in prevalence even 
when there are actually more people exposed for a long time. Third, our study could 
not measure the individual level of intakes of fluoride compared to Brazilian studies 
by the same natural experimental design (Peres et al., 2016). Given the source of 
water and types of drinking water, there was no difference in fluoride exposure 
between the two areas, so it would be difficult to see the understatement or 
overstatement of measurement. Fourth, since we used the national claim data from 
NHIS for the diseases, a single disease occurrence can result in limitations such as 
the use of multiple institutions or the accuracy of diagnosis names, and part of the 
definition of hip fracture may also worsen specificity or have a greater effect on 
estimates of the sensitivity (Berry et al., 2017). On the other hand, we analyze small 
areas in the region with claim data, hence it will not affect the results.
Strengths of our study is that it was designed to be a natural experiment 
without the intervention of researchers and we compared adverse health effects in 
the CWF and non-CWF areas. Internal comparisons within the same population 
group on a small area unit can provide a clear evidence of the effect on adverse 
health effects from the CWF. Further, the spatiotemporal analysis allowed us to 
observe the difference between the CWF and non-CWF areas and adverse health 
effects by visualizing the prevalence of disease.
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4.4 Public health implication
Prevention effect of dental caries by CWF have already been proven through a lot 
of studies and it substantially improved many nation’s dental health. Despite this, a 
small but highly vocal opposition repeatedly against the fluoridation and now many 
countries are in the situation of ceasing water fluoridation program which is a great 
loss in nationwide since a preventive program for many people around the world, 
including social minorities, to maintain oral health for a long time at low cost. 
Furthermore, opponents are in the vanguard of anti-scientific activities such as anti-
vaccination, anti-fluoridation and other forms of science denial for similar reasons
(Morabia, 2016). If CWF program stopped, they will conduct anti-scientific 
movement such as avoid vaccination and this could eventually lead to the failure of 
public health prevention service collapsing like dominoes. 
The nation’s local government is vulnerable to the voices of opponents, 
and they repeatedly bring up opposition to the community water fluoridation 
program in worldwide. In Korea, the CWF is on the verge of a complete halt, and to 
prevent this state, the Ministry of Health and Welfare need to address the public’s 
uneasiness by presenting it on the basis of a paper published into professional 
journals. The participation of experts from each local government is urgently 
needed, and although the effectiveness and benefits of public health prevention 
programs are evident, due to opposition from groups, polices and institutional 
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supplementation that the local government arbitrarily decides to suspend are 
absolutely necessary.
CHAPTER 5. CONCLUSION
Through our study, we conclude that there was no significant association between 
CWF and bone diseases (hip fracture, osteoporosis, and bone cancer). With spatio-
temporal Poisson regression analysis, implementation of water fluoridation program 
did not increase the risk of adverse health effect compared to areas where never 
implemented CWF program. 
Fluoride, consider as a double-edged sword (Unde et al., 2018). Although 
our study results consistent to previous studies, well-design epidemiological studies 
of adverse health effect or large case-control studies that linked to spatiotemporal 
method are recommended. One of the study suggested CATFISH project (Cumbrian 
Assessment of Teeth a Fluoride Intervention Study for Health) to evaluate 
reintroduction of a water fluoridation scheme (Goodwin et al., 2016). This study 
result will provide not only scientific evidence but also evidence for policy decision
on resume or discontinue of community water fluoridation program.
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APPENDIX A. Summary of systematic review results
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APPENDIX B. R-INLA coding
> fom1_hfx = hfx_case ~ f(region, model='bym', graph=cheongju) +
                             f(time, model="rw2") +
                            f(time1, model="iid") +
                             f(region.time, model="iid") + 
                            flo




> fom2_hfx = hfx_case ~ f(region, model='bym', graph=cheongju) +
                             f(time, model="rw2") +
                            f(time1, model="iid") +
                             f(region.int, model="iid",group=time.int, 
control.group=list(model="rw2")) + 
                             flo
> fom3_hfx = hfx_case ~ f(region, model='bym', graph=cheongju) +
                             f(time, model="rw2") +
f(time1, model="iid") +
                             f(time.int, model="iid", group=region.int, 
                            control.group=list(model="besag", 
graph=cheongju)) + 
                           flo
> fom4_hfx = hfx_case ~ f(region, model='bym', graph=cheongju) +
                             f(time, model="rw2") +
                             f(time1, model="iid") +
                             f(region.int, model="besag",
graph=cheongju, group=time.int, 
control.group=list(model="rw2")) + 
                           flo
These R codes are for fitting each type of formula with hip fracture. We did not
include other selected diseases (osteoporosis, bone cancer) because it also 
performed in the same way.
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APPENDIX C. CARBayesST coding
Model comparison for hip fracture
[CARBayesST]
> m1_hfx = CARBayesST::ST.CARanova(f_hfx, data=dat, W=W.mat, 
family="poisson",interaction=TRUE, 
burnin=50000, n.sample=200000, thin=5)
> m2_hfx = CARBayesST::ST.CARlinear(f_hfx, data=dat, W=W.mat, 
family="poisson",burnin=50000, n.sample=200000, 
thin=5)
> m3_hfx = CARBayesST::ST.CARar(f_hfx, data=dat, W=W.mat, 
family="poisson",burnin=50000, n.sample=200000, 
thin=5)
> m4_hfx = CARBayesST::ST.CARadaptive(f_hfx, data=dat, W=W.mat, 
family="poisson",burnin=50000, n.sample=200000, 
thin=5)
> m5_hfx = CARBayesST::ST.CARlocalised(f_hfx, data=dat, W=W.mat, 
family="poisson", G=3,burnin=5000, 
burnin=50000, n.sample=200000, thin=5)
These CARBayesST codes was used in R. We did not include other diseases 
(osteoporosis and bone cancer) codes since the codes structure are same with 
different data. 
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APPENDIX D. Compare the relative risk
Table B. Posterior distribution of relative risks (RR) with 95% credible intervals in 
different period of time.
1982-2004 1997-2004
RR* (95% CrI**)
Hip Fracture 0.96 (0.87 – 1.05) 1.07 (0.97 - 1.16)
Osteoporosis 0.96 (0.89 – 1.03) 1.10 (1.02 - 1.19)
Bone Cancer 1.20 (0.89 – 1.62) 0.96 (0.73 – 1.25)
Note.
*  RR: Relative risk
** 95% CrI: 95% Credible Interval
69
APPENDIX E. Disease mapping with three different regions





∙ Purple bold line region: CWF was conducted from 1982 to 2004 (long-term exposure)
∙ Yellow dotted line region: CWF was conducted from 1997 to 2004 (short-term exposure)
∙ Rest of region: CWF never implemented
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APPENDIX F. Outline of the methods
Table C. Outline the six models compared in this study 
Model Paper Software
Model 1 Knorr-Held (2000) ST.CARanova
Model 2 Bernardinelli et al (1995) ST.CARlinear
Model 3 Rushworth et al (2014) ST.CARar
Model 4 Rushworth et al (2017) ST.CARadaptive
Model 5 Lee and Lawson (2016) ST.CARlocalised
Model 6 Knorr-Held (2000) R-INLA
Source: Lee et al., (2018)
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APPENDIX G. RECORD statement
Table D. The RECORD statement – checklist of items, extended from the STROBE statement, that should be reported 
in observational studies using routinely collected health data
Item 
Number




(a) Indicate the study’s design with a 
commonly used term in the title or the 
abstract. (b) Provide in the abstract an 
informative and balanced summary of 
what was done and what was found. 
RECORD 1.1: The type of data used 
should be specified in the title or 
abstract. When possible, the name of 
the databases used should be included. 
RECORD 1.2: If applicable, the 
geographic region and time frame 
within which the study took place 
should be reported in the title or 
abstract. RECORD 1.3: If linkage 
between databases was conducted for 
the study, this should be clearly stated 
in the title or abstract. 
(a) Indicate the study’s design with a 
commonly used term in the title or the 
abstract. (b) Provide in the abstract an 
informative and balanced summary of 
what was done and what was found. 
RECORD 1.1: The type of data used 
should be specified in the title or 
abstract. When possible, the name of 
the databases used should be included. 
RECORD 1.2: If applicable, the 
geographic region and time frame 
within which the study took place 
should be reported in the title or 
abstract. RECORD 1.3: If linkage 
between databases was conducted for 
the study, this should be clearly stated 






Explain the scientific background and 










Present key elements of study design 
early in the paper.
Page 16
Setting 5
Describe the setting, locations, and 
relevant dates, including periods of 





(a) Cohort study: Give the eligibility 
criteria and the sources and methods 
of selection of participants. Describe 
methods of follow-up. Case-control 
study: Give the eligibility criteria and 
the sources and methods of case 
ascertainment and control selection. 
Give the rationale for the choice of 
cases and controls. Cross-sectional 
study: Give the eligibility criteria and 
the sources and methods of selection 
of participants. (b) Cohort study: For 
matched studies, give matching 
criteria and number of exposed and 
unexposed. Case-control study: For 
matched studies, give matching 
criteria and the number of controls per 
RECORD 6.1: The methods of study 
population selection (such as codes or 
algorithms used to identify subjects) 
should be listed in detail. If this is not 
possible, an explanation should be 
provided. RECORD 6.2: Any 
validation studies of the codes or 
algorithms used to select the 
population should be referenced. If 
validation was conducted for this 
study and not published elsewhere, 
detailed methods and results should be 
provided. RECORD 6.3: If the study 
involved linkage of databases, 
consider use of a flow diagram or 
other graphical display to demonstrate 
the data linkage process, including the 
Page 19
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case. number of individuals with linked data 
at each stage.
Variables 7
Clearly define all outcomes, 
exposures, predictors, potential 
confounders, and effect modifiers. 
Give diagnostic criteria, if applicable.
RECORD 7.1: A complete list of 
codes and algorithms used to classify 
exposures, outcomes, confounders, 
and effect modifiers should be 
provided. If these cannot be reported, 






For each variable of interest, give 
sources of data and details of methods 
of assessment (measurement). 
Describe comparability of assessment 




Describe any effort to address 
potential sources of bias.
N/A
Study size 10






Explain how quantitative variables 
were handled in the analyses. If 
applicable, describe which groupings 






(a) Describe all statistical methods, 
including those used to control for 
confounding. (b) Describe any 
methods used to examine subgroups 





missing data were addressed. (d) 
Cohort study: If applicable, explain 
how loss to follow-up was addressed. 
Case-control study: If applicable, 
explain how matching of cases and 
controls was addressed. Cross-
sectional study: If applicable, describe 
analytical methods taking account of 
sampling strategy. (e) Describe any 
sensitivity analyses




RECORD 12.1: Authors should 
describe the extent to which the 
investigators had access to the 
database population used to create the 
study population. RECORD 12.2: 
Authors should provide information 




RECORD 12.3: State whether the 
study included person-level, 
institutional-level, or other data 
linkage across two or more databases. 
The methods of linkage and methods 




Participants 15 (a) Report the numbers of individuals RECORD 13.1: Describe in detail the Page
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at each stage of the study (e.g., 
numbers potentially eligible, 
examined for eligibility, confirmed 
eligible, included in the study, 
completing follow-up, and analyzed). 
(b) Give reasons for nonparticipation 
at each stage. (c) Consider use of a 
flow diagram.
selection of the persons included in 
the study (i.e., study population 
selection), including filtering based on 
data quality, data availability, and 
linkage. The selection of included 
persons can be described in the text 






(a) Give characteristics of study 
participants (e.g., demographic, 
clinical, and social) and information 
on exposures and potential 
confounders. (b) Indicate the number 
of participants with missing data for 
each variable of interest. (c) Cohort 
study: summaries follow-up time (e.g., 




Cohort study: Report numbers of 
outcome events or summary measures 
over time. Case-control study: Report 
numbers in each exposure category or 
summary measures of exposure.
Cross-sectional study: Report numbers 









estimates and their precision (e.g., 
95% confidence interval). Make clear 
which confounders were adjusted for 
and why they were included. (b) 
Report category boundaries when 
continuous variables were categorized. 
(c) If relevant, consider translating 
estimates of relative risk into absolute 
risk for a meaningful time period.
Other analyses 19
Report other analyses done—e.g., 







Summarize the key results with 
reference to study objectives.
Page 48
Limitations 21
Discuss limitations of the study, 
taking into account sources of 
potential bias or imprecision. Discuss 
both direction and magnitude of any 
potential bias.
RECORD 19.1: Discuss the 
implications of using data that were 
not created or collected to answer the 
specific research question(s). Include 
discussion of misclassification bias, 
unmeasured confounding, missing 
data, and changing eligibility over 





Give a cautious overall interpretation 
of results considering objectives, 




results from similar studies, and other 
relevant evidence .
Generalisability 23
Discuss the generalizability (external 





Give the source of funding and the 
role of the funders for the present 
study and, if applicable, for the 









RECORD 22.1: Authors should 
provide information on how to access 
any supplemental information such as 





Abbreviations: N/A, not applicable








연구목적: 수돗물불소농도조정사업 (이하, 수불사업)은 청주시에 1982년
부터 2004년까지 시행되었다. 본 연구는 뼈와 관련된 질환 (고관절 골절,
골다공증, 골암)에 대한 수불사업의 위해를 역학적으로 평가하고자 한다.
연구설계: 본 연구는 자연실험 설계를 기반으로 한 생태학적 연구이다.
연구방법: 2004년부터 2013년 사이의 청주시 주민등록인구기반 거주자
를 연구 대상자로 선정하여 국민건강보험공단 국민건강자료에서 맞춤형
DB를 사용하였다. 전신건강질환 중 고관절 골절, 골다공증, 골암을 관심
질환으로 선정하였으며 관심질환 의료의용의 환자 건수를 이용하여 자연
실험으로 설계된 청주시에서의 수불사업 중단 이후 의료이용 추이를 분
석하고 질병 발생의 경향과 수불사업의 위해에 대하여 분석하였다. 읍면
동별 불소화 시행 여부와 청주시 거주민들의 관심질환의 표준화 유병률
과의 관계를 모형화 하는데 시공간적 상관성을 고려한 계층적 베이지안
시공한 포아송 회귀모형을 사용하여 분석하였다. 공간적 상관성을 통제하
80
는데 자주 사용되는 조건부 자기회귀모형(CAR)을 적용하였다. 베이지안
추론을 위한 계산 방법은 R-INLA 패키지를 사용하였다.
연구결과: 수불사업이 중단된 이후, 수불사업이 시행되었던 지역과 한번
도 시행하지 않은 지역을 비교하였을 때 관심질환의 유병률이 통계적으
로 유의한 차이가 없음을 확인하였다 (고관절 골절: RR=0.94, 95% CrI 
[0.86-1.04], 골다공증: RR=0.94, 95% CrI [0.87-1.02], 골암: RR=1.20,
95% CrI [0.89-1.61]).
결론: 국민건강보험자료를 이용하여 청주시 소지역(읍면동) 단위로 2004
년부터 2013년까지 관심질환의 의료이용에 대한 시간과 공간을 고려한
시공간 분석을 수행하였다. 수불사업 중단 이후, 시행지역과 미시행지역
간의 의료이용에 차이가 없었음을 확인하였으며 시행지역이 미시행지역
에 비해 골질환 유병률이 특별히 증가하는 추세를 발견하지 못하였다. 따
라서, 수불사업으로 인한 위해가 없었음을 확인하였다. 본 연구결과는 자
연실험을 통한 역학연구로서 수불사업의 인체위해성에 대한 과학적 근거
자료로 제공 될 수 있으며, 공중보건사업으로 꾸준히 연구하고 발전시켜
나아가야할 필요성을 제시한다.  
………………………………………………………………………………
주요어: 수돗물불소농도조정사업, 전신건강영향, 자연실험, 시공간 분석,
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